About the
Investigational Drug
About the FREEDOMS II Study
As you may know, the currently available medications for RRMS are Avonex®, Rebif®, Betaseron®, Novantrone®, Tysabri®, and Copaxone®. Studies have shown that these medications are effective in decreasing the rate and severity of relapses (as well as, in some cases, decreasing the risk that a disability caused by MS may progress).
However, all of the current RRMS medications are injected – either under the skin, into the muscle, or into the vein – causing pain and, potentially, reactions on the body where they are injected.
Because of these concerns, medical researchers are conducting clinical research studies in an effort to help develop oral treatments (treatments that are taken by mouth).
One of these studies is the FREEDOMS II study.
To find out if you may be able to participate:
